ArticleRadiology. Imaging cancer2026
Prognostic Significance of Intraindividual CT and MRI LI-RADS Agreement and Discordance in Hepatocellular Carcinoma.
Article in Radiology. Imaging cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose To assess the intraindividual concordance and discordance in Liver Imaging Reporting and Data System (LI-RADS) categorizations between CT and MRI for surgically resected hepatocellular carcinoma (HCC) and to evaluate their association with early postsurgical recurrence. Materials and Methods This dual-center retrospective study included patients who underwent both CT and MRI before hepatic resection for HCC between January 2016 and December 2020. For each HCC lesion, the LI-RADS category was independently assigned at CT and MRI. Univariable and multivariable Cox regression analyses were performed to evaluate the associations between the CT and MRI LI-RADS categorizations (LI-RADS category M [LR-M] vs LI-RADS category 4 or 5 [LR-4/5]) and 2-year recurrence-free survival (RFS) rate. Patients were classified into three groups according to the CT or MRI LI-RADS categorization: LR-M at both CT and MRI, at only one modality, or at neither CT or MRI. The 2-year RFS was compared among the groups. Results A total of 319 patients (mean age, 58.8 years ± 9.7 [SD]; 248 male patients) were included, with HCC lesions of 114 (35.7%) patients showing discrepant CT or MRI LI-RADS categorizations. LR-M categorization was more common at MRI than at CT (21.6% vs 6.0%;
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.